This panel of industry leaders will dig into the questions shaping the future of domestic drug production:
🔹 How are industry leaders, policymakers, and manufacturers working to rebuild critical pharmaceutical supply chains in North America?
🔹 What roles will national security, advanced manufacturing, and workforce development play in the future of domestic drug production?
🔹 What will it actually take to build a more resilient, reliable, and strategically competitive pharmaceutical manufacturing ecosystem in the United States?
